Health and Healthcare
5867 Articles
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details…
Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com:…
Managed health care company stocks are rising Tuesday despite press reports that hospitals will contribute $155 billion over 10 years…
Hansen Medical Inc. (NASDAQ: HNSN) is becoming the Boulevard of Broken Dreams in the land of speculative medical instrument stocks. …
Alnylam (Nasdaq: ALNY) leads a short list of some of the fastest-growing biotech stocks where analyst estimate revisions continue to…
It is hard to say whether a person is better off stopping smoking and lessening their chances of a heart…
General Electric Company (NYSE: GE) is taking a bold and controversial new step into the field of embryonic stem cell…
Boston Scientific Corporation (NYSE: BSX) is finally getting free from President and Chief Executive Officer Jim Tobin. This was one…
Everyone is trying to figure out who the winners and losers are likely to be under a watered-down healthcare program…
STAAR Surgical Company (NASDAQ: STAA) has been on a roaring run of late. In mid-May this stock was under $1.00. …
Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma…
Biotech Genzyme Corp. (Nasdaq: GENZ) reported on Friday that it has received European approval for Renvela, a newer version of…
Shares of Savient Pharmaceuticals Inc. (Nasdaq: SVNT) climbed on Friday after an announcement by the FDA that the company’s drug…
Shares in pharma firm Savient (SVNT) are up 55% to $9.13 on what would appear to be very bad news. The FDA issued…
Dendreon Corporation (NASDAQ: DNDN) was started with a Buy rating and a $36.00 target at Deutsche Bank. The call’s positive…
Our top personal finance-related articles today. Your wallet will thank you later.